12-04-2007: A multi-disciplinary UK consortium of partners including Avecia, Intertek ASG, Lonza, Paraytec and the University of Bradford has recently been awarded research grants by the Technology Strategy Board and the Engineering and Physical Sciences Research Council. The part funded £1M+ project is to develop novel analytical instrumentation to detect aggregation in biopharmaceutical processing. Aggregation or the 'sticking together' of molecules is a major problem in medicine. At best it can reduce the effectiveness of a drug and at worst it can have detrimental health effects.
Professor David Goodall, Chief Scientific Officer at Paraytec commented 'We are delighted to be lead partner in this project. Our award winning ActiPix D100 UV detection technology will play a central role in the novel analytical instrumentation. Our approach will enable simultaneous UV quantification and sizing to allow monomeric species of biopharmaceuticals to be readily distinguished from dimers and aggregates. For bioprocessing companies like Avecia and Lonza, an attraction of this technology is that UV detection is the method of choice for monitoring and quantifying biopharmaceuticals during separation and polishing stages. Thus the ability to gain additional information on size is seen as a significant benefit.'
The development project will take place over the next two years. The project will be followed by commercialization of the instrumentation by Paraytec.
Watchlist
This is where you can add this news to your personal favourites
A multi-disciplinary UK consortium of partners including Avecia, Intertek ASG, Lonza, Paraytec and the University of Bradford has recently been awarded research grants by the Technology Strategy Board and the Engineering and Physical Sciences Research Council. The part funded £1M+ project i ... more
Avecia announced that it has completed the sale of its Electronic Materials businesses (Ink jet and Electrophotography) to FUJIFILM, having obtained all necessary approvals. This successfully concludes a sale agreement previously announced on 26th December 2005.
The disposal includes all A ... more
Avecia announced that it has completed the sale of its Pharmaceuticals custom synthesis business to Nicholas Piramal India Limited (NPIL), having obtained all necessary approvals. This successfully concludes a sale agreement previously announced on 27th October 2005.
NPIL has paid GBP 9.5 ... more
Malvern Instruments Ltd and Paraytec Ltd have entered into a development and licensing agreement that will see Paraytec’s ActiPix® technology being added to Malvern’s materials characterization portfolio. The agreement will give Malvern exclusive rights to further develop, market and sell A ... more
A multi-disciplinary UK consortium of partners including Avecia, Intertek ASG, Lonza, Paraytec and the University of Bradford has recently been awarded research grants by the Technology Strategy Board and the Engineering and Physical Sciences Research Council. The part funded £1M+ project i ... more
Intertek has signed one of the Enterprise Framework Agreements (EFAs) with Shell Global Solutions International B.V which includes for the provision of site, plant and asset inspection services as well as quality assurance, Inspection, expediting and technical audit support on various proje ... more
Intertek has acquired American Analytical Chemistry Laboratories Corp (AACL), a testing, analytics and research company focusing on food, functional foods, nutritional supplements, cosmeceuticals and pharmaceuticals.Based in Champaign, Ill., AACL provides analytical testing and research ser ... more
Intertek announced the acquisition of Ciba Expert Services' Environmental, Safety, & Testing and Regulatory businesses, including Cantox Health Sciences and Ashuren Health Sciences.
The acquisition substantially strengthens Intertek's scope and depth for regulatory consulting to meet custo ... more
Intertek ASG provides comprehensive laboratory services in chemical analysis for Pharmaceutical, Biotechnology and Speciality Chemical companies. These services include multi-faceted offerings for complex characterization, problem solving, regulatory analysis and combined regulatory package ... more